Search research articles
Contact Us
Filters
Showing results (91-100 of 130) with videos related to
Page
of 13
Sort By:
Proteomics. Clinical Applications
|
July 10, 2020
Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells
Bjoern C Froehlich, Robert Popp, Constance A Sobsey, et al.
The Analyst
|
September 29, 2021
A multiplexed, automated immuno-matrix assisted laser desorption/ionization mass spectrometry assay for simultaneous and precise quantitation of PTEN and p110α in cell lines and tumor tissues
Bjoern C Froehlich, Robert Popp, Constance A Sobsey, et al.
International Journal of Molecular Sciences
|
April 23, 2022
A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens
Georgia Mitsa, Qianyu Guo, Christophe Goncalves, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2022
3D chromatin remodeling potentiates transcriptional programs driving cell invasion
Benjamin Lebeau, Maïka Jangal, Tiejun Zhao, et al.
Cell Reports
|
May 3, 2018
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
Marie-Anne Goyette, Stéphanie Duhamel, Léo Aubert, et al.
Cell Reports
|
December 15, 2023
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
Marie-Anne Goyette, Stéphanie Duhamel, Léo Aubert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2026
Clinical Validation of Digital PCR-based ctDNA detection for risk stratification in residual triple negative breast cancer: TRICIA trial results
Talia Roseshter, Anna Klemantovich, Josiane Lafleur, et al.
Cancer Research Communications
|
April 13, 2026
ATR and PKMYT1 inhibition re-sensitize a subset of TNBC patient-derived models to carboplatin inducing mitotic catastrophe
Juliet Guay, Hellen Kuasne, Catherine Chabot, et al.
Cell Metabolism
|
September 15, 2015
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Fanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, et al.
NAR Cancer
|
October 9, 2025
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment
Nouritza Torossian, Marc Gabriel, Panagiotis Papoutsoglou, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 130) with videos related to
Sort By:
Page
of 13
Proteomics. Clinical Applications
|
July 10, 2020
Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells
Bjoern C Froehlich, Robert Popp, Constance A Sobsey, et al.
The Analyst
|
September 29, 2021
A multiplexed, automated immuno-matrix assisted laser desorption/ionization mass spectrometry assay for simultaneous and precise quantitation of PTEN and p110α in cell lines and tumor tissues
Bjoern C Froehlich, Robert Popp, Constance A Sobsey, et al.
International Journal of Molecular Sciences
|
April 23, 2022
A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens
Georgia Mitsa, Qianyu Guo, Christophe Goncalves, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2022
3D chromatin remodeling potentiates transcriptional programs driving cell invasion
Benjamin Lebeau, Maïka Jangal, Tiejun Zhao, et al.
Cell Reports
|
May 3, 2018
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
Marie-Anne Goyette, Stéphanie Duhamel, Léo Aubert, et al.
Cell Reports
|
December 15, 2023
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
Marie-Anne Goyette, Stéphanie Duhamel, Léo Aubert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2026
Clinical Validation of Digital PCR-based ctDNA detection for risk stratification in residual triple negative breast cancer: TRICIA trial results
Talia Roseshter, Anna Klemantovich, Josiane Lafleur, et al.
Cancer Research Communications
|
April 13, 2026
ATR and PKMYT1 inhibition re-sensitize a subset of TNBC patient-derived models to carboplatin inducing mitotic catastrophe
Juliet Guay, Hellen Kuasne, Catherine Chabot, et al.
Cell Metabolism
|
September 15, 2015
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Fanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, et al.
NAR Cancer
|
October 9, 2025
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment
Nouritza Torossian, Marc Gabriel, Panagiotis Papoutsoglou, et al.
Page
of 13